Impact of imaging frequency on progression-free survival in Alliance trials enrolling patients with follicular lymphoma

Blood Adv. 2024 Mar 26;8(6):1464-1468. doi: 10.1182/bloodadvances.2023012090.
No abstract available

MeSH terms

  • Antibodies, Monoclonal, Murine-Derived
  • Diagnostic Imaging
  • Humans
  • Lymphoma, Follicular* / diagnosis
  • Lymphoma, Follicular* / therapy
  • Progression-Free Survival
  • Rituximab

Substances

  • Rituximab
  • Antibodies, Monoclonal, Murine-Derived